Search - tctmd.com

Displaying 41 - 53 of 53

Sort: Relevancy | Date

FOURIER: Evolocumab Reduces Risk of CVD Events by 15% Compared With Placebo

News Conference News ACC 2017

FOURIER: Evolocumab Reduces Risk of CVD Events by 15% Compared With Placebo

Michael O'Riordan

March 17, 2017

News Conference News AHA 2016

鉴于动脉粥样硬化 CVD 的上升趋势，治疗成本应该刺激政策制定者推广预防

Yael L. Maxwell

November 29, 2016

News Conference News AHA 2016

En mitad de la Marea Creciente de ECVA, los Costes del Tratamiento Deberían hacer que los Legisladores Legislasen en Materia de Prevención

Yael L. Maxwell

November 29, 2016

News Conference News AHA 2016

Amid Rising Tide of Atherosclerotic CVD, Costs of Treatment Should Spur Policy Makers to Push Prevention

Yael L. Maxwell

November 29, 2016

News Daily News

特朗普逆转获胜，美国心脏病学家也纷纷震惊

November 09, 2016

News Daily News

Trump’s Unexpected Win Met With Everything From Shock to Optimism Among US Cardiologists

November 09, 2016

News Daily News

La Inesperada Victoria de Trump Desata el Estupor y el Optimismo a Partes Iguales entre los Cardiólogos Norteamericanos

November 09, 2016

News Daily News

CAC Screening Stratifies CVD Event Risk in Statin-Eligible Patients: Heinz Nixdorf Recall Study

Michael O'Riordan

September 22, 2016

News Daily News

Noninvasive Testing Can Safely Spare a Large Proportion of Elderly Patients From Statin Therapy

Michael O'Riordan

August 23, 2016

News Daily News

与心血管疾病相关的乳房 X 线检查结果经常被忽略和不报告

March 25, 2016

News Daily News

Mammogram-Derived Clues to Cardiovascular Disease Often Unreported and Ignored

March 25, 2016

News Daily News

Las Pistas de Enfermedad Cardiovascular que arrojan las Mamografías Suelen Pasarse por Alto

March 25, 2016

News Daily News

Optimal Risk Factor Control Translates Into Less Expenditure on Healthcare, Use of Resources

Michael O'Riordan

March 02, 2016

Country

First Name

Last Name

Email

Profession

Organization

Country

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.